Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol.

Plasma levels of HDL apo A-I are reduced in individuals with low HDL cholesterol (HDL-C) concentrations as a result of increased fractional catabolic rates (FCRs). To determine the basis for the high apo A-I FCRs, seven subjects with low HDL-C levels (31.0 +/- 4.3 mg/dl) were compared with three subjects with high HDL-C levels (72.0 +/- 4.5 mg/dl). Each subject received autologous HDL that was labeled directly by the iodine-monochloride method (whole-labeled) and autologous HDL that was labeled by exchange with homologous radiolabeled apo A-I (exchange-labeled). Blood was obtained for 2 wk, specific activities determined, and FCRs (d-1 +/- SD) estimated. In every subject, whether in the low or high HDL-C group, the exchange-labeled FCR was greater than the whole-labeled FCR. The exchange-labeled FCR was higher in the low HDL-C group (0.339 +/- 0.043) versus the high HDL-C group (0.234 +/- 0.047; P < 0.009). The whole-labeled FCR was also greater in the low HDL-C group (0.239 +/- 0.023) versus the high HDL-C group (0.161 +/- 0.064; P < 0.02). In addition, in both low and high HDL groups ultracentrifugation resulted in more radioactivity in d > 1.210 (as percentage of total plasma counts per minute) with the exchange-labeled tracer than with the whole-labeled tracer (12.55 +/- 4.95% vs. 1.02 +/- 0.38%; P < 0.003). With both HDL tracers, more radioactivity was found in d > 1.210 in the low versus the high HDL-C groups. When apo A-I catabolism was studied by perfusing isolated rabbit kidneys with whole-labeled HDL, there was twice as much accumulation (cpm/g cortex) of HDL apo A-I isolated from subjects with low HDL-C than from subjects with high HDL-C (P < 0.0025). Finally, HDL that had been isolated from subjects with high levels of HDL-C was triglyceride enriched and exposed to partially purified lipases before perfusion through kidneys. Threefold more apo A-I from modified HDL accumulated in the cortex compared with the unmodified preparation (P < 0.007). The results of these in vivo and ex vivo studies indicate that individuals with low HDL-C levels have more loosely bound, easily exchanged apo A-I and that this exchangeable apo A-I is more readily cleared by the kidney.

[1]  S. Grundy,et al.  Evaluation of a method for study of kinetics of autologous apolipoprotein A-I. , 1991, Journal of lipid research.

[2]  P. Barter,et al.  Hepatic lipase promotes a loss of apolipoprotein A-I from triglyceride-enriched human high density lipoproteins during incubation in vitro. , 1991, Arteriosclerosis and thrombosis : a journal of vascular biology.

[3]  S. Eisenberg,et al.  Increased apo A-I and apo A-II fractional catabolic rate in patients with low high density lipoprotein-cholesterol levels with or without hypertriglyceridemia. , 1991, The Journal of clinical investigation.

[4]  W. Blaner,et al.  Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys. , 1990, The Journal of clinical investigation.

[5]  P. Barter,et al.  Lipoprotein lipase prevents the hepatic lipase-induced reduction in particle size of high density lipoproteins during incubation of human plasma. , 1990, Atherosclerosis.

[6]  S. Eisenberg,et al.  Elevated high density lipoprotein cholesterol levels correlate with decreased apolipoprotein A-I and A-II fractional catabolic rate in women. , 1989, The Journal of clinical investigation.

[7]  R. Neary,et al.  The effect of renal failure and haemodialysis on the concentration of free apolipoprotein A-1 in serum and the implications for the catabolism of high-density lipoproteins. , 1988, Clinica chimica acta; international journal of clinical chemistry.

[8]  R. Neary,et al.  Stability of free apolipoprotein A-1 concentration in serum, and its measurement in normal and hyperlipidemic subjects. , 1987, Clinical chemistry.

[9]  D. Gordon,et al.  High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial. , 1986, Circulation.

[10]  P. Wilson,et al.  Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. , 1986, JAMA.

[11]  H. Greten,et al.  Quantitative determination of apolipoprotein A-I in high-density lipoproteins and 'free' apolipoprotein A-I by two-dimensional agarose gel lipoprotein-'rocket' immunoelectrophoresis of human serum. , 1986, Biochimica et biophysica acta.

[12]  D. Steinberg,et al.  Uptake of high-density lipoprotein-associated apoprotein A-I and cholesterol esters by 16 tissues of the rat in vivo and by adrenal cells and hepatocytes in vitro. , 1985, The Journal of biological chemistry.

[13]  R. Jackson,et al.  Preparation of a homogeneous and stable form of bovine milk lipoprotein lipase. , 1985, Preparative biochemistry.

[14]  S. Eisenberg,et al.  High density lipoprotein metabolism. , 1984, Journal of lipid research.

[15]  D. Gebhardt,et al.  The Immunochemical Determination of Apolipoprotein A, Total Apolipoprotein A-I and ‘Free’ Apolipoprotein A-I in Serum of Patients on Chronic Haemodialysis , 1984, Annals of clinical biochemistry.

[16]  K. Saku,et al.  Renal handling of high-density lipoproteins by isolated perfused kidneys. , 1984, Metabolism: clinical and experimental.

[17]  A. Sniderman,et al.  Apoproteins B and A-I and coronary artery disease in humans. , 1984, Arteriosclerosis.

[18]  D. Steinberg,et al.  Tissue sites of degradation of apoprotein A-I in the rat. , 1983, The Journal of biological chemistry.

[19]  H. Brewer,et al.  Human apolipoprotein A-I and A-II metabolism. , 1982, Journal of lipid research.

[20]  T. Maack Physiological evaluation of the isolated perfused rat kidney. , 1980, The American journal of physiology.

[21]  A. Gotto,et al.  The in vitro interaction of human apolipoprotein A-I and high density lipoproteins. , 1977, Biochimica et biophysica acta.

[22]  M. Kashyap,et al.  High density lipoproteinuria in nephrotic syndrome. , 1976, Metabolism: clinical and experimental.

[23]  C. Ehnholm,et al.  A comparative study of post-heparin lipolytic activity and a purified human plasma triacylglycerol lipase. , 1974, Biochimica et biophysica acta.

[24]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.

[25]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.